Latest Acute respiratory distress syndrome Stories
Follow-up SURFAXIN® (lucinactant) Data Analysis Presented at 2013 Pediatric Pharmacy Advocacy Group Annual Meeting WARRINGTON, Pa., June 11, 2013 /PRNewswire/ -- Discovery Laboratories, Inc. (NASDAQ: DSCO) today announced the presentation of the last in a series of pharmacoeconomic analyses indicating that a reduction in the rate of reintubation( )among preterm infants may potentially result in hospital cost-savings related to fewer reintubation-related diagnoses of...
WARRINGTON, Pa., June 10, 2013 /PRNewswire/ -- Discovery Laboratories, Inc. (NASDAQ: DSCO), a specialty biotechnology company dedicated to advancing a new standard in respiratory critical care, today announced that on June 7,( )2013 it submitted a response to the U.S. Food and Drug Administration's (FDA) recent correspondence relating to Discovery Labs' recently updated product specifications for SURFAXIN(®). Discovery Labs expects that the FDA may take up to four months to review...
SAN DIEGO, June 5, 2013 /PRNewswire/ -- Genoa Pharmaceuticals, the leader in inhaled medicines for pulmonary fibrosis, and collaborators Drs. Martin Kolb and Kjetil Ask at McMaster University announced today the measured advantages of inhaled GP-101 (aerosol pirfenidone) in the treatment of pulmonary fibrosis. Utilizing the standard in vivo model of bleomycin-induced pulmonary fibrosis, we have demonstrated that small inhaled doses yielding high peak, short duration lung...
University of Maryland School of Medicine Trauma Surgeon considers death of one of Civil War’s most renowned generals, struck down by friendly fire in 1863, at the 20th Annual Clinicopathological Conferences sponsored by University of Maryland School of Medicine and VA Maryland Health Care System. Baltimore, Md (PRWEB) May 09, 2013 It has been 150 years to the day since Thomas Jonathan “Stonewall” Jackson died after being struck by friendly fire from his own Confederate troops...
Use of SpHb® Noninvasive Hemoglobin Is Part of Leading Medical Teaching Facility's Standardization to Masimo SET® Pulse Oximetry BURSA, Turkey and IRVINE, Calif., May 8, 2013 /PRNewswire/ -- Masimo (NASDAQ: MASI) and Uludag University Hospital, one of the top educational healthcare facilities in all of Turkey, announce that Uludag has added Masimo SpHb(® )- a breakthrough technology that allows clinicians to noninvasively and continuously monitor hemoglobin blood levels. The use...
WARRINGTON, Pa., April 15, 2013 /PRNewswire/ -- Discovery Laboratories, Inc. (NASDAQ: DSCO), a specialty biotechnology company dedicated to advancing a new standard in respiratory critical care, today announced that the U.S. Food and Drug Administration (FDA) has requested clarification and provided recommendations regarding the recently-updated product specifications for SURFAXIN(®). Discovery Labs plans to provide a response to the FDA within two months. FDA procedure provides up...
Julie Halston, Debbie Gravitte, Max von Essen, Emily Bergyl, Robert Creighton, Klea Blackhurst, Emma Hunton, and Edward Watts Join Legendary Belter Linda Lavin for the Third Annual Broadway Belts for PFF! NEW YORK, Feb. 26, 2013 /PRNewswire-USNewswire/ -- With honors ranging from the Golden Globes to the Tony Awards, Broadway's best performers gathered Monday night to raise awareness of the rare disease, pulmonary fibrosis (PF), and honor the memory of Associated Press theater...
WARRINGTON, Pa., Feb. 13, 2013 /PRNewswire/ -- Discovery Laboratories, Inc. (NASDAQ: DSCO), a specialty biotechnology company dedicated to advancing a new standard in respiratory critical care, today announced that it has entered into a secured loan facility with Deerfield Management Company, L.P. (Deerfield) for up to $30.0 million in financing. Deerfield is a leading healthcare investment firm with more than $3.5 billion of assets currently under management. "We are...
74-year-old Lung Disease Doctor Not Giving Up Now Even After 40 Years of Searching DENVER, Jan. 28, 2013 /PRNewswire-USNewswire/ -- Dr. Marvin Schwarz isn't ready for retirement, though several years ago, he stepped down from his position as head of the Pulmonary Sciences Critical Care Medicine Division at the University of Colorado Medical Center. Schwarz, a 74-year-old pulmonologist and lung disease researcher hasn't found what he's been looking for despite more than 40 years of...
American ALDES’ Zone Register Terminal (ZRT-2) received the 2013 AHR Expo Innovation Award for Ventilation. The ZRT-2 is now a finalist for the 2013 Product of the Year, which will be chosen from among the 10 category award winners and announced at the AHR Expo, January 28-30, 2013, in Dallas. American ALDES will be exhibiting at Booth #536. Bradenton, FL (PRWEB) January 15, 2013 American ALDES’ Zone Register Terminal (ZRT-2) received the 2013 AHR Expo Innovation Award for...
